Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS) Plans Monthly Dividend of $0.09

Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS) announced a monthly dividend on Thursday, March 12th. Shareholders of record on Tuesday, April 7th will be given a dividend of 0.0905 per share by the investment management company on Thursday, April 30th. This represents a c) dividend on an annualized basis and a dividend yield of 15.5%. The ex-dividend date is Tuesday, April 7th.

Neuberger Berman High Yield Strategies Fund Stock Down 2.8%

Shares of NYSEAMERICAN:NHS traded down $0.21 during trading on Friday, hitting $7.03. 134,423 shares of the company were exchanged, compared to its average volume of 147,702. The business’s 50 day moving average is $7.53 and its 200-day moving average is $7.44. Neuberger Berman High Yield Strategies Fund has a 1-year low of $6.62 and a 1-year high of $7.80.

Institutional Trading of Neuberger Berman High Yield Strategies Fund

Hedge funds and other institutional investors have recently made changes to their positions in the company. Mercer Global Advisors Inc. ADV acquired a new position in Neuberger Berman High Yield Strategies Fund during the 3rd quarter worth approximately $80,000. Integrity Advisory Solutions LLC acquired a new stake in Neuberger Berman High Yield Strategies Fund in the 4th quarter valued at $81,000. CoreCap Advisors LLC acquired a new position in Neuberger Berman High Yield Strategies Fund during the third quarter worth $94,000. XTX Topco Ltd bought a new stake in shares of Neuberger Berman High Yield Strategies Fund during the second quarter worth about $113,000. Finally, MRA Advisory Group grew its holdings in Neuberger Berman High Yield Strategies Fund by 10.9% during the third quarter. MRA Advisory Group now owns 17,261 shares of the investment management company’s stock worth $129,000 after buying an additional 1,693 shares in the last quarter.

About Neuberger Berman High Yield Strategies Fund

The Neuberger Berman High Yield Strategies Fund (NYSE American: NHS) is a closed-end, fixed-income management investment company focused on delivering high current income with the potential for capital appreciation. The fund primarily invests in below-investment-grade corporate debt—often referred to as high-yield bonds—issued by U.S. and select non-U.S. issuers. Through a diversified portfolio of high-yield instruments, NHS aims to provide enhanced yield relative to investment-grade alternatives.

Under its investment policy, NHS allocates the majority of its assets to corporate securities spanning sectors such as communications, energy, consumer goods, and industrials.